HDAC11, an emerging therapeutic target for metabolic disorders

H Chen, C Xie, Q Chen, S Zhuang - Frontiers in Endocrinology, 2022 - frontiersin.org
Histone deacetylase 11 (HDAC11) is the only member of the class IV HDAC, and the latest
member identified. It is highly expressed in brain, heart, kidney and some other organs, and …

HDAC9-mediated epithelial cell cycle arrest in G2/M contributes to kidney fibrosis in male mice

Y Zhang, Y Yang, F Yang, X Liu, P Zhan, J Wu… - Nature …, 2023 - nature.com
Renal tubular epithelial cells (TECs) play a key role in kidney fibrosis by mediating cycle
arrest at G2/M. However, the key HDAC isoforms and the underlying mechanism that are …

Renoprotective mechanisms of exercise training against acute and chronic renal diseases–A perspective based on experimental studies

LFL Malheiro, MM Fernandes, CA Oliveira… - Life Sciences, 2024 - Elsevier
Regular exercise training can lead to several health benefits, reduce mortality risk, and
increase life expectancy. On the other hand, a sedentary lifestyle is a known risk factor for …

A single chain variable fragment antibody (Tn 64) cognate to fibronectin type III repeats promotes corneal wound healing by inhibiting fibrosis

A Shukla, V Suresh, PC Gupta, M Sharma… - International …, 2024 - Elsevier
Corneal wound healing requires epithelial reorganization and stromal extracellular matrix
(ECM) remodeling, with ECM proteins such as Tenascin C (TnC) regulating and maintaining …

Epigenetic and metabolic reprogramming of fibroblasts in Crohn's disease strictures reveals histone deacetylases as therapeutic targets

A Lewis, DT Humphreys, B Pan-Castillo… - Journal of Crohn's …, 2024 - academic.oup.com
Abstract Background and Aims No effective therapeutic intervention exists for intestinal
fibrosis in Crohn's disease [CD]. We characterized fibroblast subtypes, epigenetic and …

Development of renal fibrosis in patients with chronic kidney disease: Mechanisms, biomarkers, and clinical implications

L Denova - Ukrainian Journal of Nephrology and Dialysis, 2023 - ukrjnd.com.ua
CKD is a global health concern with significant implications for patients' well-being,
morbidity, and mortality. The underlying mechanism of CKD development often involves …

Cell and rat serum, urine and tissue metabolomics analysis elucidates the key pathway changes associated with chronic nephropathy and reveals the mechanism of …

L Wang, X Yu, H Li, D He, S Zeng, Z Xiang - Chinese Medicine, 2023 - Springer
Background Rhein can significantly delay the progression of chronic nephropathy. However,
its mechanism of action has not been adequately elaborated, which hinders its extensive …

Targeting polo‐like kinase 1 to treat kidney diseases

H Kulkarni, N Dagar, AB Gaikwad - Cell Biochemistry and …, 2024 - Wiley Online Library
Globally,∼ 850 million individuals suffer from some form of kidney disease. This staggering
figure underscores the importance of continued research and innovation in the field of …

METTL3-Mediated N6-methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis

YC Tsai, TH Hsieh, YR Liao, MT Tsai… - Journal of the …, 2024 - journals.lww.com
Background Chemical modifications on RNA profoundly impact RNA function and
regulation. m 6 A, the most abundant RNA modification in eukaryotes, plays a pivotal role in …

The effect of antioxidant therapy on the course of predialysis chronic kidney disease in a patient with comorbidity

LD Denova - KIDNEYS, 2023 - kidneys.zaslavsky.com.ua
Chronic kidney disease (CKD) is almost always associated with comorbidities such as
diabetes, hyperuricemia/gout, urolithiasis, often with urinary tract infection, hypertension …